Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 67   

Articles published

APPY 3.66 +0.07 (1.95%)
price chart
Venaxis Inc. APPY (US: Nasdaq)
News Venaxis Inc.APPY. No news for APPY in the past two years. Key Stock Data ? P/E Ratio (TTM): The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted ...
Stocks to Keep Your Eyes on Neothetics Inc (NASDAQ:NEOT), Venaxis Inc (NASDAQ ...
Shares of Neothetics Inc (NASDAQ:NEOT) flew +14.58% to $1.20 at 2:06 PM EDT. The stock attained the volume of 2.06 Million shares recently versus average trading volume of 793,682.00 shares.
INVESTOR ALERT: Class Action Lawsuit Against Venaxis, Inc. Announced By Glancy ...
LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of a class (the “Class”) comprising purchasers of the securities ...
Noble Equity Capital Management Issues Letter To Venaxis Shareholders
Given that the stock of Venaxis is trading at a 60% discount to its tangible book value, we find the announced merger with Strand to be value destructive for shareholders.
Why Numerous Upside Scenarios Make Venaxis A Biotech To Buy (APPY)
With news being very light on names that I cover over the past few weeks, I wanted to initiate a new name today: Venaxis (NASDAQ:APPY).
Venaxis, Inc. (NASDAQ:APPY) Posts Basic Consolidated EPS Of $-2.2607
Venaxis, Inc. (NASDAQ:APPY) received of $-2.2607 EPS boost from the parent company for the annual period ended. For the year ended 2015-12-31, the parent of Venaxis, Inc. (NASDAQ:APPY) contributed EPS of $-2.2607 to the company's bottom-line.
Venaxis, Inc. (APPY) Broker Price Targets For The Coming Week
Venaxis, Inc. has a 50 day moving average of 3.39 and a 200 day moving average of 2.88. The stock's market capitalization is 12.25M, it has a 52-week low of 1.60 and a 52-week high of 6.65.
Venaxis, Inc. (NASDAQ:APPY) Registers a Net Consolidated EPS Of $-2.2607  Equities Focus
What Every Investor Needs To Know About Venaxis, Inc.
Computed tomography imaging is used to diagnose approximately 35% of these cases, but comes with a heavy radioactive price tag. Accuracy of computer tomography imaging is measured at 93-98%.
Venaxis, Inc. (NASDAQ:APPY) Consolidated Diluted EPS At -2.2607
For the year ended 2015-12-31 Venaxis, Inc. (NASDAQ:APPY) basic consolidated EPS came $-2.2607. Furthermore, for the quarter closed 2015-12-31, it was $-2.2607.
Venaxis Inc (APPY) Stock Crashes On FDA's “Not Substantially Equivalent” Response
Venaxis Inc (NASDAQ:APPY) has received "not substantially equivalent" remarks on its blood-based diagnostic test, APPY1, from the US Food and Drug Administration (FDA).
Venaxis Receives FDA "Not Substantially Equivalent" Response on ...  PR Newswire (press release)